Title : Physostigmine for Alzheimer's disease.

Pub. Date : 2001

PMID : 11405996






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 BACKGROUND: The main pharmacological approach for the treatment of Alzheimer"s disease (AD) has been based on the use of agents potentiating cholinergic transmission, particularly by inhibiting acetylcholinesterase (AChE), the enzyme that destroys acetylcholine after it has been secreted into the synaptic clefts. Acetylcholine acetylcholinesterase (Cartwright blood group) Homo sapiens